8-Bromo-1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid, with CAS number 109347-94-6, is a synthetic organic compound belonging to the class of quinolines. This compound features a bicyclic structure characterized by a quinoline core, which is further substituted with a bromine atom, a cyclopropyl group, and a fluorine atom, contributing to its unique chemical properties. The presence of a piperazine moiety enhances its potential for biological activity, making it of interest in medicinal chemistry, particularly in the development of pharmaceuticals. The carboxylic acid functional group suggests that it may exhibit acidic properties, influencing its solubility and reactivity in various environments. Additionally, the compound's structural complexity may lead to interesting interactions with biological targets, potentially impacting its pharmacokinetics and pharmacodynamics. Overall, this compound exemplifies the intricate design often found in drug development, where specific substitutions are made to optimize therapeutic efficacy and minimize side effects.

8-bromo-1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid

109347-94-6: 8-Bromo-1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid, with CAS number 109347-94-6, is a synthetic organic compound belonging to the class of quinolines. This compound features a bicyclic structure characterized by a quinoline core, which is further substituted with a bromine atom, a cyclopropyl group, and a fluorine atom, contributing to its unique chemical properties. The presence of a piperazine moiety enhances its potential for biological activity, making it of interest in medicinal chemistry, particularly in the development of pharmaceuticals. The carboxylic acid functional group suggests that it may exhibit acidic properties, influencing its solubility and reactivity in various environments. Additionally, the compound's structural complexity may lead to interesting interactions with biological targets, potentially impacting its pharmacokinetics and pharmacodynamics. Overall, this compound exemplifies the intricate design often found in drug development, where specific substitutions are made to optimize therapeutic efficacy and minimize side effects.

PD 163449 is a bioactive molecule of 4-pyridone group that inhibits bacterial type IIA topoisomerase (DNA gyrase and topoisomerase IV).

CAS 109347-94-6

8-bromo-1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid

PD 163449

Ref: TM-T71459